Product Information
VALSARTAN-HYDROCHLOROTHIAZIDE 160-25 MG TAB is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.1245 per EA under NDC 00378632377. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Sep 21, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25; 160 mg/1; mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378632377
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
HYDROCHLOROTHIAZIDE; VALSARTANApproval Type
Generic (ANDA)
FDA Application
ANDA078020FDA Approved
9/21/2012
TE Code
AB
On Market Since
9/21/2012
Pharmacological Classes
Price Statistics
The NADAC for VALSARTAN-HYDROCHLOROTHIAZIDE 160-25 MG TAB has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 64.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1245 per EA |
|---|---|
| All-time high | $0.4435 (Sep 16, 2020) |
| All-time low | $0.1245 (Aug 19, 2026) |
| 52-week high | $0.1680 |
| 52-week low | $0.1245 |
| Median price | $0.2515 |
| Average price | $0.2533 |
| Largest weekly change | +39.6% (Aug 21, 2024) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of VALSARTAN-HYDROCHLOROTHIAZIDE 160-25 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for VALSARTAN-HYDROCHLOROTHIAZIDE 160-25 MG TAB, manufactured by Mylan Pharmaceuticals Inc., is $0.1245 per EA (NDC 00378632377), effective Aug 19, 2026.
How has the price of VALSARTAN-HYDROCHLOROTHIAZIDE 160-25 MG TAB changed over time?
Over the history we have for it, the NADAC for VALSARTAN-HYDROCHLOROTHIAZIDE 160-25 MG TAB has declined 64.3%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for VALSARTAN-HYDROCHLOROTHIAZIDE 160-25 MG TAB?
Since Nov 28, 2013, the NADAC for VALSARTAN-HYDROCHLOROTHIAZIDE 160-25 MG TAB has ranged from a low of $0.1245 (Aug 19, 2026) to a high of $0.4435 (Sep 16, 2020), with a median of $0.2515 per EA.
Are there cheaper alternatives to VALSARTAN-HYDROCHLOROTHIAZIDE 160-25 MG TAB?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as VALSARTAN-HYDROCHLOROTHIAZIDE 160-25 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures VALSARTAN-HYDROCHLOROTHIAZIDE 160-25 MG TAB?
VALSARTAN-HYDROCHLOROTHIAZIDE 160-25 MG TAB (NDC 00378632377) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.